Tristel (AIM: TSTL) – cracking results and positive outlook bring out more upgrades
The AIM quoted manufacturer of infection prevention and contamination control products, announces excellent ‘audited’ results for the year ahead of expectations with a resulting upgrade from the house broker.
The Group’s proprietary chlorine dioxide formulation and the Company addresses three distinct markets:
- The Human Healthcare market (hospital infection prevention - via the Tristel brand) represents 85% of Group sales
- The Contamination Control market (control of contamination in critical environments - via the Crystel brand)
- The Animal Healthcare market (veterinary practice infection prevention - via the Anistel brand)
Tristel’s proprietary chlorine dioxide chemistry has two…
Previous article Next article
